Protara Therapeutics, Inc. (TARA)

Protara Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	39.59	24.13	35.72	168.65	0.56
Short-Term Investments	25.99	60.24	55.51	0	0
Cash & Cash Equivalents	65.58	84.37	91.23	168.65	0.56
Cash Growth	-22.27%	-7.52%	-45.91%	29802.13%	-97.42%
Other Current Assets	3.13	1.78	1.88	0.79	0.2
Total Current Assets	68.71	86.15	93.11	169.44	0.76
Property, Plant & Equipment	6.56	7.87	8.89	2.3	0.46
Long-Term Investments	0.75	18.63	40.21	0.75	0
Goodwill and Intangibles	0	0	29.52	29.52	0
Other Long-Term Assets	2.94	0.64	0.87	1.16	0
Total Long-Term Assets	10.25	27.14	79.48	33.72	0.46
Total Assets	78.95	113.29	172.6	203.16	1.22
Accounts Payable	2.43	1.59	0.95	0.91	0.72
Current Debt	0.98	0.92	0.86	0.09	0
Other Current Liabilities	2.73	3.24	2.49	1.91	2.64
Total Current Liabilities	6.15	5.74	4.3	2.92	3.35
Long-Term Debt	4.48	5.47	6.38	1	0
Total Long-Term Liabilities	4.48	5.47	6.38	1	0
Total Liabilities	10.63	11.21	10.68	3.91	3.35
Total Debt	5.47	6.38	7.24	1.09	0
Debt Growth	-14.36%	-11.81%	565.96%	-	-
Retained Earnings	-200.38	-159.96	-94.01	-46.76	-12.78
Comprehensive Income	-0.03	-0.69	-0.21	0	0
Shareholders' Equity	68.32	102.08	161.91	199.24	-2.13
Net Cash / Debt	60.11	77.99	83.99	167.56	0.56
Net Cash / Debt Growth	-22.92%	-7.15%	-49.87%	29609.40%	-97.42%
Net Cash Per Share	5.31	6.93	7.48	23.16	0.22
Working Capital	62.56	80.41	88.81	166.52	-2.59
Book Value Per Share	6.03	9.07	14.41	27.54	-0.83

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).